Author Profile

Written By

Matt Toussant, Ph.D.

Senior Vice President, Product & Content Operations

Latest Content from Matt Toussant, Ph.D.

November 16, 2018

Leveraging the biologics boom for your drug development pipeline

The recent explosive growth of the biologics sector looks set to continue and their therapeutic use is increasingly being recognized as a fourth major method in cancer therapy (alongside the well-established approaches of surgery, chemotherapy and radiotherapy). With their suitability for individualized treatment, biologics will also play a key role in the development of precision medicine, another major area of focus for researchers, healthcare providers, investors and pharmaceutical companies. To predict and fully leverage the potential of biologics, it is important to understand the intricacies of this complex market.

September 7, 2018

An evolving partnership: The future of man and machine

"When you’re finished changing, you’re finished." Business leaders likely weren't the intended audience when Benjamin Franklin uttered his now famous quote. However, his words likely resonate deeply with leaders in today's rapidly evolving marketplace who know that for their business to thrive, they must be prepared to adapt and embrace new technologies.

June 1, 2018

Descriptive analytics still deliver: A cosmetics case study

Analysis of public data resources provides valuable general insights on a particular market, region or technology area. However, when more specific, actionable conclusions are needed to drive the strategy of your organization, a custom analytics project can provide much deeper insights.

March 22, 2018

The importance of human-curated data enrichment for big data analysis

Learn how getting big data enrichment right in scientific fields still requires human intelligence.